MRGPRX2 and allergic disease: Interestingly, the MC stabilizing H1 antihistamine ketotifen was shown to directly inhibit both IgE- and MRGPRX2-dependent activation, expanding upon previous research and supporting its use in both IgE-dependent allergy as well as non-IgE-dependent disorders such as clonal MC disorders (60, 61).